LEGN Legend Biotech Corporation

NASDAQ
$19.32

Legend Biotech Corporation (LEGN) is expected to report earnings on November 16, 2026, before the market open. The consensus earnings estimate is $0.01 per share, and the stock has had a Post-Earnings Announcement Drift (PEAD) of -11.3% since its last earnings release on August 11, 2026.

Legend Biotech Missed Expectations
Tuesday, August 11, 2026 · 7:00 AM ET
Earnings Date
3rd Quarter, Sep 2026
Nov 16
Monday · 7:00 AM ET
Earnings Whisper
-
vs $0.01
Rev est $356.51M
Volatility
Enter your expectations below to reveal the current volatility.
Trend Analysis
Expectation
Earnings
Price action
Signals
Score
Sentiment
Grade
Life Cycle
Call Analysis
Earnings-AVWAP $19.81

Sign in or subscribe to unlock sentiment, short interest, and technical indicators.

About Legend Biotech Corporation

Legend Biotech is a global clinical-stage biopharmaceutical company engaged in the discovery and development of novel cell therapies for oncology and other indications.

Sector

Healthcare

Industry

Biotechnology

Held By 7 ETFs, by dollar flow

Charts powered in part by Lightweight Charts™ by TradingView.